Observational studyJournal of orthopaedic surgery and research2025
Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study.
Observational study in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWhile venous thromboembolism (VTE) prophylaxis is crucial following major orthopaedic surgeries including total knee arthroplasty (TKA), the impact of different prophylactic agents on postoperative hemoglobin (Hb) levels remains inadequately studied. The aim of this study was to compare the effects of aspirin, rivaroxaban, and low-molecular-weight heparin (LMWH) on early postoperative Hb changes following TKA.
methodsIn this single-center retrospective cohort study, 655 primary TKAs were finally included using data from the hospital information system. Patients received either aspirin, rivaroxaban, or LMWH for VTE prophylaxis. The primary outcome was the magnitude of Hb reduction, calculated as the difference between the Hb level on the first postoperative day and the minimum postoperative Hb level before discharge. The secondary outcome was the trajectory of postoperative Hb changes within the first week.
resultsPostoperative Hb levels clearly declined within the first week, with a mean of 13.9 g/L (SD, 8.5) from postoperative day 1 in the entire cohort. In the fully adjusted linear regression model, both rivaroxaban (β = 1.5, [95%CI, 0.0 to 3.0]) and low-molecular-weight heparin (LMWH) (β = 3.3, [95%CI, 1.5 to 5.2]) were associated with a greater reduction in Hb compared to aspirin. Regarding the trajectory of postoperative Hb changes, the generalized additive mixed model revealed no statistically significant difference between rivaroxaban and aspirin (β = -0.2, [95%CI, -0.6 to 0.2]). LMWH was associated with a greater daily reduction in Hb levels relative to aspirin, averaging 0.8 g/L per day (β = -0.8, [95%CI, -1.3 to -0.3]). Despite these observed differences, the effect sizes were small, suggesting a lack of clinical significance.
conclusionsHemoglobin levels declined significantly following TKA within the first week after surgery. However, no clinically meaningful distinction is discernible between the three most frequently used pharmacological agents, aspirin, rivaroxaban and LMWH. LEVEL OF EVIDENCE: III, A retrospective cohort study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.